日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells

利用配体修饰的脂质纳米载体靶向F2R/PAR1,以增强药物向卵巢癌细胞的递送。

Khetan, Riya; Rajapaksha, Weranga; Nturubika, Bukuru D; Gillam, Todd A; Brooks, Doug A; Garg, Sanjay; Blencowe, Anton; Albrecht, Hugo; Eldi, Preethi

Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression

前列腺癌中囊泡运输机制表达的改变会影响溶酶体动力学,并有助于深入了解其潜在的生物学机制和疾病进展。

Bukuru D Nturubika,Carlos M Guardia,David C Gershlick,Jessica M Logan,Carmela Martini,Jessica K Heatlie,Joanna Lazniewska,Courtney Moore,Giang T Lam,Ka L Li,Ben S-Y Ung,Robert D Brooks,Shane M Hickey,Andrew G Bert,Philip A Gregory,Lisa M Butler ,John J O'Leary,Douglas A Brooks #,Ian R D Johnson #

Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication.

细胞外囊泡和隧道纳米管作为前列腺癌细胞间通讯的介质

Heatlie Jessica K, Lazniewska Joanna, Moore Courtney R, Johnson Ian R D, Nturubika Bukuru D, Williams Ruth, Ward Mark P, O'Leary John J, Butler Lisa M, Brooks Doug A